Protocol for PRBC Transfusion in Pediatric Patients with Elevated Liver Function Tests

Transfusion Thresholds and Decision-Making

The American College of Physicians and the American Gastroenterological Association recommend initiating PRBC transfusion when hemoglobin falls below 7 g/dL in hemodynamically stable pediatric patients with liver disease 2, 4
For patients with active bleeding or hemodynamic instability, transfusion should be guided by clinical parameters rather than hemoglobin levels alone, as suggested by the American Association for the Study of Liver Diseases 1, 5
In patients with portal hypertensive bleeding, maintaining hemoglobin between 7-9 g/dL using a restrictive transfusion approach is recommended by the American Association for the Study of Liver Diseases 1, 5
Transfusing single units (or weight-appropriate volumes for pediatric patients) and reassessing clinical status and hemoglobin level after each unit is advised by the Society of Critical Care Medicine 3, 6

For children with portal hypertension, excessive transfusion may increase portal pressure and potentially worsen bleeding, according to the American Association for the Study of Liver Diseases 1, 5

Continuously monitoring vital signs, including heart rate, blood pressure, and oxygen saturation during transfusion, is recommended by the Society of Critical Care Medicine 3
Assessing for symptoms of anemia that might warrant transfusion even with hemoglobin >7 g/dL, including tachycardia unresponsive to fluid resuscitation, hypotension, or signs of tissue hypoxia, is suggested by the American College of Physicians 2, 4
Reassessing hemoglobin levels after each unit transfused to avoid over-transfusion is advised by the American College of Physicians 2, 7

A landmark randomized controlled trial demonstrated that a restrictive transfusion strategy (Hb <7 g/dL) was associated with better outcomes than a liberal strategy (Hb <9 g/dL) in patients with gastrointestinal bleeding, particularly those with cirrhosis, as reported by the American Association for the Study of Liver Diseases 1, 5
Multiple guidelines consistently recommend restrictive transfusion strategies for patients with liver disease to avoid complications including increased portal pressure, according to the American Association for the Study of Liver Diseases and the American College of Physicians 1, 2, 5

Addressing coagulopathy if present, though INR is not a reliable indicator of bleeding risk in liver disease, is recommended by the American Association for the Study of Liver Diseases 1, 5
Considering antibiotic prophylaxis in patients with cirrhosis and gastrointestinal bleeding is suggested by the American Association for the Study of Liver Diseases 1, 5
For patients with active variceal hemorrhage, vasoactive drugs should be initiated alongside appropriate transfusion strategy, as advised by the American Association for the Study of Liver Diseases 1, 5

Avoiding over-transfusion based solely on laboratory values without considering clinical status is recommended by the American College of Physicians and the Society of Critical Care Medicine 2, 3
Not using a liberal transfusion strategy (Hb threshold >7-8 g/dL) in stable patients with liver disease is advised by the American Association for the Study of Liver Diseases and the American College of Physicians 1, 2, 5
Avoiding rapid volume expansion which can increase portal pressure in patients with portal hypertension is recommended by the American Association for the Study of Liver Diseases 1, 5
Not automatically correcting coagulopathy with fresh frozen plasma based solely on elevated INR in liver disease patients is suggested by the American Association for the Study of Liver Diseases 1, 5